• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • UK / Ireland

Bridges Ventures backs Orla Healthcare

  • Harriet Bailey
  • Harriet Bailey
  • 27 May 2014
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Bridges Ventures has invested in Orla Healthcare, a London-based service delivering acute medical care at home.

One of the company's aims is to ease pressure on A&E units, having already signed its first NHS contract with an Essex hospital where the new service is being piloted.

Also this month, Bridges committed capital to Brighton-based care provider Alina Homecare, which also provides care services within the home. The company states it aims to work closely with patients, local authorities, the NHS and other relevant organisations to improve integration between health and social care.

Orla Healthcare

  • DEAL:

    Expansion

  • LOCATION:

    London

  • SECTOR:

    Healthcare providers

  • FOUNDED:

    2012

Bridges made the investment from its Sustainable Growth Fund III, a £125m vehicle that closed in October last year exceeding its £100m target. This is its fifth investment from the fund, which aims to make three to five investments per year. Bridges typically invests £2-15m in either later-stage businesses that are generating revenues of £5-50m, or start-ups seeking capital to scale up.

Previous investors 3i and Doughty Hanson have committed to the fund, with The European Investment Fund as a new backer and cornerstone investor. According to Bridges, the third fund invests in SMEs operating in the healthcare, education and environmental sectors, as well as under-served areas. The company states 80% of its investments go into companies in the most deprived parts of the UK.

Company
Orla's services are based on the Australian ‘Hospital in the Home' concept, provided in New South Wales since 1994. Based in London, the company was founded by Rory McCrea and Sarah Chilvers in 2012. The model aims to improve patient outcomes and patient satisfaction by providing an alternative delivery of care at a lower cost to hospital care.

The service is led by consultants with 24/7 supervision and specially developed clinical processes, systems and technologies. Orla claims patients opting for the service will receive the same standard of care and monitoring as in hospital, while hospital bed spaces are freed up for other treatment purposes. It also claims care in the home has been shown to deliver benefits including reduced patient stress and faster recovery times, particularly for the elderly.

People
Garret Turley is partner and Ian Taylor is investment director at Bridges. David Harrop is CEO of Orla.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • UK / Ireland
  • Healthcare
  • Expansion
  • United Kingdom
  • Bridges Ventures

More on UK / Ireland

Fund closes in US dollars
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • Funds
  • 05 September 2023
Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
Public sector software
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • Exits
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013